Sanzone Virginia Ruth, ICU MEDICAL INC/DE’s VP and General Counsel, sold 4,856 shares across four transactions at prices ranging from $167.67 to $171.51 per share. Investors can see that her reported ownership after the transactions stood at 14,604 shares, the disclosed position tied to the sale.
Key Highlights
- The transactions took place on 3 September 2026.
- Each of the four sales used transaction code S.
- Sanzone Virginia Ruth held 14,604 shares after the transactions.
Sanzone Virginia Ruth sold 4,856 ICU MEDICAL INC/DE (NASDAQ: ICUI) shares at prices ranging from $167.67 to $171.51 per share. Sanzone, the company’s VP and General Counsel, completed the sales on 3 September 2026 across four transactions.
Four Transactions Carry Code S
Each transaction was recorded under code S, and the combined activity covered 4,856 ICU MEDICAL INC/DE shares. The reported prices extended from $167.67 to $171.51 per share across the transactions. Sanzone Virginia Ruth’s reported ownership after the transactions was 14,604 shares. That figure represents Sanzone’s position following the completed sales.
FAQs
Q: How many ICU Medical shares did Sanzone Virginia Ruth sell?
A: Sanzone Virginia Ruth sold 4,856 ICU MEDICAL INC/DE shares. The sales occurred across four transactions at prices ranging from $167.67 to $171.51 per share.
Q: When did the ICU Medical executive stock sale occur?
A: The executive stock sale took place on 3 September 2026, when Sanzone Virginia Ruth sold 4,856 shares across four separate transactions. Each transaction was recorded using transaction code S.
Q: How many shares did Sanzone Virginia Ruth own after selling?
A: Sanzone Virginia Ruth’s reported ownership after the ICU Medical share sales was 14,604 shares. She is identified as the company’s VP and General Counsel.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.